日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Personalized neoadjuvant strategy using 70-gene assay to increase breast-conserving surgery in ER+/HER2- breast cancer

采用70基因检测的个性化新辅助治疗策略,以提高ER+/HER2-乳腺癌患者的保乳手术率

Han, Wonshik; Kang, Eunhye; Jung, Ji Gwang; Kim, Hong-Kyu; Lee, Han-Byoel; Kim, Jisun; Lee, Sae Byul; Shin, Hee-Chul; Park, Chan Sub; Seong, Min-Ki; Kim, Hyun-Ah; Kim, Eun-Kyu; Son, Byung Ho

Proapoptotic role of CDK1 in overcoming paclitaxel resistance in ovarian cancer cells in response to combined treatment with paclitaxel and duloxetine

CDK1 在克服紫杉醇和度洛西汀联合治疗引起的卵巢癌细胞紫杉醇耐药性中的促凋亡作用

Gyeongmi Kim, Se-Kyeong Jang, Se Hee Ahn, Selim Kim, Chan Sub Park, Min-Ki Seong, Hyun-Ah Kim, Seunghee Bae, Jae Ho Lee, Hyunggee Kim, Hyeon-Ok Jin, In-Chul Park

Breast Cancer Statistics in Korea, 2021

2021年韩国乳腺癌统计数据

Cha, Chihwan David; Park, Chan Sub; Shin, Hee-Chul; Han, Jaihong; Choi, Jung Eun; Kim, Joo Heung; Jung, Kyu-Won; Lee, Sae Byul; Nam, Sang Eun; Yoon, Tae In; Kang, Young-Joon; Kim, Zisun; Jung, So-Youn; Kim, Hyun-Ah

Breast Cancer Statistics in Korea, 2019

2019年韩国乳腺癌统计数据

Choi, Jung Eun; Kim, Zisun; Park, Chan Sub; Park, Eun Hwa; Lee, Sae Byul; Lee, Se Kyung; Choi, Young Jin; Han, Jaihong; Jung, Kyu-Won; Kim, Hee Jeong; Kim, Hyun-Ah

Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors

奈必洛尔增强 BT-474 乳腺癌细胞对 FGFR 抑制剂的敏感性

Yu Jin Kim #, Se-Kyeong Jang #, Gyeongmi Kim, Sung-Eun Hong, Chan Sub Park, Min-Ki Seong, Hyun-Ah Kim, Kwang Seok Kim, Chun-Ho Kim, Ki Soo Park, Jungil Hong, Hyeon-Ok Jin, In-Chul Park

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy

对乳腺癌患者确诊第二原发性恶性肿瘤后的生存分析,重点关注第二原发性血液系统恶性肿瘤

Kim, Hyung Jin; Lee, Juhyeon; Park, In-Chul; Han, Yireh; Seong, Min-Ki; Noh, Woo Chul; Kang, Hye Jin; Kim, Hyun-Ah; Park, Chan Sub

Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?

对于接受促性腺激素释放激素激动剂和三苯氧胺治疗的 N0 或 N1 期内分泌敏感型乳腺癌患者,是否可以省略化疗?

Lee, Juhyeon; Park, Chan Sub; Oh, Jeong Hun; Park, In-Chul; Seong, Min-Ki; Noh, Woo Chul; Kim, Hyun-Ah

The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer

p-AKT1 作为激素受体阳性和人类表皮生长因子受体 2 阳性早期乳腺癌患者的预后标志物和治疗靶点的意义

Ji Yea Kim #, Chan Sub Park #, Se-Kyeong Jang, Hyesil Seol, Min-Ki Seong, Woo Chul Noh, In-Chul Park, Hyun-Ah Kim

Aesthetic Scar-Less Mastectomy and Breast Reconstruction

无疤痕乳房切除术和乳房重建术

Yang, Jung Dug; Lee, Jeeyeon; Lee, Joon Seok; Kim, Eun Kyu; Park, Chan Sub; Park, Ho Yong

Value of accurate diagnosis for metastatic supraclavicular lymph nodes in breast cancer: assessment with neck US, CT, and 18F-FDG PET/CT

准确诊断乳腺癌锁骨上淋巴结转移的价值:颈部超声、CT 和 18F-FDG PET/CT 的评估

Lee, Jeeyeon; Park, Ho Yong; Kim, Wan Wook; Park, Chan Sub; Lee, Ryu Kyung; Kim, Hye Jung; Kim, Won Hwa; Lee, Sang Woo; Jeong, Shin Young; Chae, Yee Soo; Lee, Soo Jung; Park, Ji Young; Park, Jee-Young; Jung, Jin Hyang